Indications for Thymectomy
Thymectomy is indicated for two primary conditions: thymic tumors (thymomas and thymic carcinomas) as an absolute indication, and myasthenia gravis as a relative indication for symptom management.
Absolute Indications
Thymic Tumors (Thymomas and Thymic Carcinomas)
Complete surgical resection is the standard of care for all resectable thymomas and thymic carcinomas in patients who can tolerate the procedure 1.
The procedure should involve total thymectomy with complete excision of the entire thymus gland, including all mediastinal tissues anterior to the pericardium, aorta, and superior vena cava from phrenic nerve to phrenic nerve laterally, and from the diaphragm inferiorly to the thyroid gland superiorly 2.
Completeness of resection is a critical predictor of outcome, with 10-year survival rates for resected thymoma approximately 90%, 70%, 55%, and 35% for Masaoka stages I, II, III, and IVa disease, respectively 1.
For thymic carcinoma with complete (R0) resection, the 5-year survival rate is estimated at 60-70% 1.
An open median sternotomy surgical approach is recommended as the standard of care for thymoma resection, while minimally invasive approaches (e.g., video-assisted thoracic surgery) are not considered standard of care at this time 2.
Additional Tumor-Related Indications
- Thymectomy is necessary for hyperparathyroidism with ectopic intrathymic parathyroids or certain forms of multiple endocrine neoplasia 3.
Relative Indications
Myasthenia Gravis
Thymectomy plays a central role in the complex therapy of autoimmune-related myasthenia gravis, particularly for acetylcholine receptor antibody-positive patients 3, 4.
Approximately one-third of patients with thymomas have myasthenia gravis as the most common paraneoplastic syndrome 1.
For patients with acetylcholine receptor antibody-positive myasthenia gravis and those with thymoma, the benefits of thymus removal well outweigh potential risks 4.
Other Autoimmune Conditions
The value of thymectomy is proven in myasthenia gravis but questionable in ulcerative colitis and erythroblastopenia 5.
Systemic lupus erythematosus is a contraindication to thymectomy 5.
Important Caveats
When to Avoid Biopsy
Surgical biopsy should be avoided if a resectable thymoma is strongly suspected based on clinical and radiologic features (e.g., patients with myasthenia gravis and characteristic mass on CT) 1.
A transpleural approach should be avoided during biopsy of a possible thymoma 1.
Small biopsy sampling (fine-needle or core needle biopsy) does not indicate whether invasion is present 1.
Incidental Thymic Tissue Removal
- Incidental removal of thymic tissue during other thoracic surgeries should be minimized whenever feasible, as there are concerns about long-term risks of cancer and autoimmunity post-thymectomy 4.
Stage-Specific Considerations
For Masaoka-Koga stage I thymic carcinomas with no capsular invasion and complete (R0) resection, postoperative therapy is not recommended 1.
For stage I thymoma, neither postoperative nor neoadjuvant radiotherapy or systemic therapy is recommended 2.
For stage II thymoma, routine adjuvant radiation is not recommended, but should be considered in patients with high risk for local recurrence (invasion through capsule, close surgical margins, WHO grade B type, tumor adherent to pericardium) 2.